Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BLRX | F | BioLineRx Ltd. | 6.31 | |
BBIO | F | BridgeBio Pharma, Inc. | 2.26 | |
CLDX | D | Celldex Therapeutics, Inc. | 0.11 | |
CRVO | B | CervoMed Inc. | -4.68 | |
CPIX | D | Cumberland Pharmaceuticals Inc. | 3.53 | |
CYTK | D | Cytokinetics, Incorporated | 0.83 | |
DCPH | C | Deciphera Pharmaceuticals, Inc. | 3.31 | |
DCTH | B | Delcath Systems, Inc. | 0.76 | |
EQ | D | Equillium, Inc. | -5.52 | |
FGEN | F | FibroGen, Inc | 1.96 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BTEC | C | Principal Healthcare Innovators Index ETF | 3.45 | |
XBI | D | SPDR S&P Biotech ETF | 3.44 | |
BBP | D | BioShares Biotechnology Products Fund | 3.32 | |
HRTS | D | Tema Cardiovascular and Metabolic ETF | 2.93 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 2.8 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles